One of the world’s most recognizable digital billboards now features TibaRay among the innovative companies it highlights
Our team has spent years working toward a future where cancer treatment is faster, more precise and more accessible for patients around the world.”— Thinh Tran, CEO of TibaRaySILICON VALLEY, CA, UNITED STATES, July 29, 2026 /EINPresswire.com/ — Today, TibaRay, a medical technology company based in Silicon Valley, was showcased on the Nasdaq Tower in New York City’s Times Square after being chosen by Lehigh University’s Startup Academy. This recognition highlights the company’s advancement toward bringing next-generation precision radiation therapy to market. The milestone adds to a series of recent achievements, including ongoing development of the Galactica™ platform, as the Stanford-born enterprise strives to deliver cutting-edge cancer treatment solutions to patients.
This placement positions TibaRay among the forward-thinking companies appearing on one of the globe’s most iconic digital displays, underscoring the firm’s momentum and increasing prominence within the medtech sector. The opportunity arose from TibaRay’s collaboration with Lehigh University’s Startup Academy, which nominated the company for the billboard due to its novel approach to fighting cancer and its dedication to entrepreneurial values.
Rooted in Stanford University research, TibaRay is creating Galactica, an upright linac radiation therapy system designed to enhance patient comfort while delivering highly targeted cancer treatment in a more compact and efficient configuration. The platform also establishes a foundation for future FLASH therapy, an emerging treatment option that administers radiation in under a second and has demonstrated the ability to effectively destroy tumors while limiting harm to surrounding healthy tissue.
"Every milestone brings us one step closer to making the next generation of radiation therapy available to patients," said Thinh Tran, CEO of TibaRay. "Our team has spent years working toward a future where cancer treatment is faster, more precise and more accessible for patients around the world. Being featured on the Nasdaq Tower is an exciting moment that reinforces our commitment to bringing this innovative technology to the patients who need it most."
Radiation therapy is employed in the treatment of nearly half of all cancer patients, highlighting the need for ongoing innovation that boosts precision, efficiency, and patient experience. As TibaRay continues to move toward commercialization, the company stays focused on speeding up the development of next-generation radiation therapy technologies that could improve outcomes, broaden access to advanced cancer care, and shape the future of oncology.
Those interested in supporting TibaRay’s ongoing growth can find details about its current investment opportunity at Wefunder.com/TibaRay. For additional information, please visit TibaRay.com.
###
About TibaRay
TibaRay is a medical technology company that advances innovative linear accelerator technology for radiotherapy and other commercial applications. The company’s next-generation accelerator platform is engineered to help physicians deliver radiotherapy with improved precision, speed, and efficiency, while also enabling broader uses of compact, high-performance linear accelerators beyond cancer care.
Founded on technology developed at Stanford University, TibaRay combines expertise in physics, engineering, and medicine to advance the future of radiation technology. Headquartered in Fremont, California, TibaRay is driven by its mission of Curing Cancer in a FLASH™. To learn more, visit TibaRay.com.
###
Karla Nafarrate
InnoVision Marketing Group
email us here
